IMU 0.00% 4.9¢ imugene limited

Ann: First Cohort 2 Patient Dosed in Clinical Trial of CHECKvacc, page-82

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 525 Posts.
    lightbulb Created with Sketch. 115
    Morning all, little checkvacc update.
    In keeping with cohort 1, hopefully we get an announcement anytime now stating that the dose escalation for cohort 2 has no toxicity and patient 2 is now being dosed….unless like some eluded too, might already be in the clinic receiving their doses.

    Patient 1, in cohort 2, must be doing well as expected, and in just over a weeks time, will be receiving dose number 5 out of 6.

    cheers
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.